Viewing Study NCT00964158


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-05-20 @ 9:38 AM
Study NCT ID: NCT00964158
Status: COMPLETED
Last Update Posted: 2018-02-19
First Post: 2009-08-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 113528
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators